Fox Run Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Fox Run Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-33,724	Closed	-$425K	–	886
2025 Q4	$425K	Buy	+33,724	New	+$386K	0.07%	565
2025 Q1	–	Sell	-20,435	Closed	-$162K	–	896
2024 Q4	$162K	Buy	20,435 +8,342	+69%	+$70K	0.03%	776
2024 Q3	$101K	Buy	+12,093	New	+$94.6K	0.02%	741
2021 Q3	–	Sell	-14,184	Closed	-$73K	–	455
2021 Q2	$73K	Buy	+14,184	New	+$80.6K	0.07%	325
2019 Q3	–	Sell	-24,749	Closed	-$177K	–	352
2019 Q2	$177K	Buy	+24,749	New	+$253K	0.12%	377
2018 Q3	–	Sell	-13,872	Closed	-$228K	–	560
2018 Q2	$228K	Buy	+13,872	New	+$243K	0.07%	533

Other funds holding AMRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return